Has John Carey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,250 in general payments to John Carey, MD across 114 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Carey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Carey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Carey, MD

Interventional Pain Medicine · Jacksonville, FLNPI 1821069055

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,813 of the $5,250 with a category attached, or 72.6%. 26 manufacturers reported payments, led by Medtronic at 51.4% of the total. 2025 is the largest year on record at $2,352, 6.8 times the $346 reported in 2019. That places this record below the midpoint for interventional pain medicine clinicians in FL, where the typical reported total is $4,625.

$5,250in general payments, 2019–2025

Across 114 payments — averaging $46.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$3K
Boston Scientific$694
Abbott$642
AbbVie$386
Painteq LLC$135
Relievant Medsystems, Inc.$133
plus $564 from 20 others

What the payments were for

Travel & lodging$1,25724%
Food & beverage$3,81373%
Education$1803%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	32	$2,697
Boston Scientific	15	$694
Abbott	17	$642
AbbVie(2 entities)	19	$386
Painteq LLC	2	$135
Relievant Medsystems, Inc.	1	$133
Pfizer	4	$65
Johnson & Johnson	2	$51
Vertos Medical, Inc.	1	$40
Si-bone, Inc.	1	$37
Tersera Therapeutics LLC	2	$37
Curonix LLC	2	$32
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$31
Alkermes, Inc.	1	$29
Arbor Pharmaceuticals, Inc.	2	$28
Stimwave Technologies Incorporated	1	$27
Protega Pharmaceutials Inc	1	$26
Scilex Pharmaceuticals Inc.	1	$24
Biotronik NRO, Inc.	1	$23
Inogen, Inc.	1	$22
Amgen	1	$19
Lundbeck LLC	1	$18
Merz North America, Inc.	1	$17
Nevro Corp.	1	$14
Novartis	1	$12
Eisai Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,250 in reported general payments places this provider in the 50th percentile of 278 interventional pain medicine providers in Florida.

See all interventional pain medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$227,723

Medicare patients

433

Services billed

3,832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	567	$18,509
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	702	$17,986
Fentanyl	47	$4,253
Oxycodone Hcl	231	$3,849
Pregabalin	207	$3,041
Tramadol Hcl	271	$2,208
Morphine Sulfate ErMorphine Sulfate	78	$2,104
Celecoxib	106	$1,970
Lidocaine	23	$1,533
Baclofen	111	$1,455
Gabapentin	132	$1,024
Acetaminophen-CodeineAcetaminophen With Codeine	23	$863
Morphine Sulfate	35	$662
Methocarbamol	25	$327
Diazepam	263	$272

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Jacksonville

Justin MannJacksonville$243K
Huber Matos-GarsaultJacksonville$48K
Justin AlfonsoJacksonville$33K
Kenneth EaddyJacksonville$28K
David SalekJacksonville$25K
Maggie GarciaJacksonville$22K
Alexis JimenezJacksonville$18K
Beric BerliozJacksonville$17K
Louis RasoJupiter$1.3M
Ajay AntonyGainesville$1.1M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →